Autumn 2008 (Pdf)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Autumn 2010 (Pdf)
The Genome Scientist UW Genome Sciences | www.gs.washington.edu | Volume 5 No 1 | Autumn 2010 Genome Sciences Welcomes Five New Faculty Members Dr. Elhanan Borenstein Dr. James Bruce Dr. Su-In Lee Dr. Judit Villen Dr. Alejandro Wolf-Yadlin The Genome Scientist is published by the Department of Genome Sciences at the University of Washington. For more information, please see our website, www.gs.washington.edu. NOTES FROM THE CHAIR What a time to be in Genome Sciences! The Along with our research, education continues to thrive at past two years have been an exciting, yet all levels. Our graduate program is exceptional. Incoming challenging time. students these past couple years have been simply outstand- ing; current students are publishing exciting papers; graduat- As you can see from the cover, we have ing students are securing excellent post-docs. Time to degree welcomed fi ve outstanding new faculty into is falling. In the undergraduate arena we are revamping our the Department – Elhanan Borestein, Jim basic genetics course. As part of this we have recruited Mi- Bob Waterston Bruce, Su-In Lee, Judit Villen, and Alejandro chelle Smith to join the faculty as a Lecturer. She comes from Wolf-Yadlin. They bring real strengths in a post-doctoral NSF sponsored teaching program at the Uni- computational biology and proteomics to what are already versity of Colorado and will help organize the revised genetics strong programs. The diversity of their backgrounds is strik- course. Celeste Berg and Bonnie Brewer have also created a ing, and they connect us with new areas intellectually, on “CSI-Seattle” course for a small group of incoming freshmen. -
Current Positions
Jay Shendure, MD, PhD Updated December 31, 2020 Current Positions Investigator, Howard Hughes Medical Institute Professor, Genome Sciences, University of Washington Director, Allen Discovery Center for Cell Lineage Director, Brotman Baty Institute for Precision Medicine Contact Information E-mail: [email protected] Lab website: http://krishna.gs.washington.edu Office phone: (206) 685-8543 Education • 2007 M.D., Harvard Medical School (Boston, Massachusetts) • 2005 Ph.D. in Genetics, Harvard University (Cambridge, Massachusetts) Research Advisor: George M. Church Thesis entitled “Multiplex Genome Sequencing and Analysis” • 1996 A.B., summa cum laude in Molecular Biology, Princeton University (Princeton, NJ) Research Advisor: Lee M. Silver Professional Experience • 2017 – present Scientific Director Brotman-Baty Institute for Precision Medicine • 2017 – present Scientific Director Allen Discovery Center for Cell Lineage Tracing • 2015 – present Investigator Howard Hughes Medical Institute • 2015 – present Full Professor (with tenure) Department of Genome Sciences, University of Washington, Seattle, WA • 2010 – present Affiliate Professor Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA • 2011 – 2015 Associate Professor (with tenure) Department of Genome Sciences, University of Washington, Seattle, WA • 2007 – 2011 Assistant Professor Department of Genome Sciences, University of Washington, Seattle, WA • 1998 – 2007 Medical Scientist Training Program (MSTP) Candidate Department of Genetics, Harvard Medical School, Boston, WA • 1997 – 1998 Research Scientist Vaccine Division, Merck Research Laboratories, Rahway, NJ • 1996 – 1997 Fulbright Scholar to India Department of Pediatrics, Sassoon General Hospital, Pune, India 1 Jay Shendure, MD, PhD Honors, Awards, Named Lectures • 2019 Richard Lounsbery Award (for extraordinary scientific achievement in biology & medicine) National Academy of Sciences • 2019 Jeffrey M. Trent Lectureship in Cancer Research National Human Genome Research Institute, National Institutes of Health • 2019 Paul D. -
Summer 2005 (Pdf)
T H E G E N O M E S C I E N T I S T Volume 2, Number 1 Summer 2005 DEPARTMENT ADDS THREE FACULTY MEMBERS Joshua Akey, Assistant Professor Joshua Akey, Ph.D., joined Genome Sciences last fall from the Fred Hutchinson Cancer Research Center where he had been a postdoctoral fellow in the Kruglyak Lab. Dr. Akey commented that “there were many features that attracted me to Genome Sciences, including the strength, breadth, and collegiality of the faculty and a strong graduate pro- gram.” Well known in the fields of population Evan Eichler, genetics and molecular evolution, Dr. Associate Professor Akey has research interests that include understanding how evolutionary forces Evan Eichler, shape patterns of genetic variation Ph.D., joined within and between species and how we Genome Sci- UW Genome Sciences www.gs.washington.edu continued on page 2 ences in May 2004 from , Case Western Michael MacCoss Reserve Uni- Assistant Professor versity, not- IN THIS ISSUE: Michael ing that “Ge- MacCoss, Ph.D., nome Sciences combines the strengths came to Ge- of a more traditional genetics program New Faculty 1-2 nome Sciences while taking advantage of new devel- Notes from the Chair 2 in December opments in genome technology and Fangman Symposium 3 2003 from the computer science. I am excited by the Foege Building 3 Scripps Insti- prospects – genomics with a strong Faculty Honors 4-5 tute, where he genetic backbone is poised to make News & Notes 6-7 had been a some of the most significant contribu- Research Highlights 8-12 postdoctoral fellow in the Yates Lab. -
Autumn 2002 (Pdf)
he Genome Scientist TUniversity of Washington Department of Genome Sciences Newsletter/Volume 1, Number 1/Fall 2002 Robert H. Waterston, M.D., Ph.D. to Chair the Department of Genome Sciences Dr. Robert H. Waterston will chair the recently formed Department of Genome Sciences and will hold the endowed William H. Gates III Chair in Biomedical Sciences. An innovator in genome research, Dr Waterston will lead the Department in exciting new areas. The goals of the Department are well matched to those of Dr. Waterston: bring together model organism biologists, computational biologists, and technology developers to speed the analysis needed to interpret the genome. “It’s a magnificent opportunity,” said Dr. Waterston. “They have marshaled the resources to make this a very strong program.” Stan Fields, Acting Chair, said, “We are tremendously excited...we will be able to hire new faculty and move into new areas of biology.” At 58, Bob Waterston is internationally recognized as a leader in genome sequencing and the International Human Genome Project. His awards include the 2002 International Gairdner Award for outstanding achieve- ment in biomedical research (see page 8), election to the National Academy of Sciences, the 2000 George W. Beadle Medal, the first Dan David Prize, and the Alfred P. Sloan Award. Dr. Waterston’s achievements in genome research began early on in his career. In the mid-80’s, together with John Sulston of the Sanger Centre, he proposed one of the largest scientific ventures ever attempted: the sequence of Caenorhabditis elegans, “the worm.” In the face of scientific skepticism Dr. Waterston forged ahead, creating the Genome Sequencing Center in St. -
SULSTON Medical Research Council Laboratory of Molecular Biology and Wellcome Trust Sanger Institute, Cambridge, CB10, 1SA, United Kingdom
C. elegans: THE CELL LINEAGE AND BEYOND Nobel Lecture, December 8, 2002 by JOHN E. SULSTON Medical Research Council Laboratory of Molecular Biology and Wellcome Trust Sanger Institute, Cambridge, CB10, 1SA, United Kingdom. Thank you so very much for inviting me to be here. It gives me a mingled sense – of humility at how much I owe to others, and of joy that the collective work on the worm has been recognised in this way. Among the first of my many mentors was my PhD supervisor, Colin Reese, who was developing non-aqueous methods for oligonucleotide synthesis (e.g. Fromageot et al., 1968). Colin passed me on to my postdoctoral supervisor Leslie Orgel at the Salk Institute, to work on prebiotic chemistry. The plan was to see to what extent we could copy RNA chains without enzymes. The products were in low yield, and the challenge was to work out the sequences that had been produced. We used cutting with different ribonucleases, and chromatography to separate the fragments (e.g. Sulston et al., 1968). My introduction to C. elegans came in 1969 with my move, at Leslie's sug- gestion, to Sydney Brenner's group at the Medical Research Council's Laboratory of Molecular Biology (Figure 1). Sydney was reputed to be setting Figure 1. Sydney Brenner, laboratory and Caernorhabditis elegans. Photo: MRC Laboratory of Molecular Biology. 363 up a group to work on the nervous system of a nematode, though at that point nobody knew much about it (Brenner, 1973). Sydney had already collected numerous mutations that affected the behav- iour of the worms (Brenner,1974), and one of my first projects was to investi- gate the level of glutamate decarboxylase in them, for GABA was believed to function as an inhibitory transmitter. -
2000 Thomas Hunt Morgan Medal
Copyright 2001 by the Genetics Society of America The 2000 GSA Honors and Awards The Genetics Society of America annually honors members who have made outstanding contributions to genetics. The Thomas Hunt Morgan Medal recognizes a lifetime contribution to the science of genetics. The Genetics Society of America Medal recognizes particularly outstanding contributions to the science of genetics within the past ®fteen years. The George W. Beadle Medal recognizes distinguished service to the ®eld of genetics and the community of geneticists. We are pleased to announce the 2000 awards. The 2000 Thomas Hunt Morgan Medal Evelyn M. Witkin Evelyn M. Witkin HEN one meets Evelyn Witkin, one is struck both the ®eld and give it cohesion. Despite her extreme im- W by her intellectual boldness and her personal portance to this ®eld, if Evelyn herself were writing this modesty. From the beginning, Evelyn was propelled by perspective, it would be a bare-bones account indeed, a desire to answer big questions; her achievements are the very antithesis of a self-promotional document. a testimony to the power of that approach. Evelyn de- Evelyn's Ph.D. studies on induced mutagenesis imme- cided on graduate work in genetics because she felt it diately established her intellectual independence. Al- important to test Tro®m Lysenko's now largely discred- though working with Theodosius Dobzhansky, she ited ideas on how heredity could be altered by the envi- chose to use E. coli rather than Drosophila as her experi- ronment. After a few months of study, she realized that mental organism, having been in¯uenced by the 1943 his theory had no merit. -
Joint Proclamation by the Heads of Government of Six Countries Regarding the Completion of the Human Genome Sequence
Joint Proclamation by the Heads of Government of Six Countries Regarding the Completion of the Human Genome Sequence We, the Heads of Government of the United States of America, the United Kingdom, Japan, France, Germany, and China, are proud to announce that scientists from our six countries have completed the essential sequence of three billion base pairs of DNA of the human genome, the molecular instruction book of human life. Remarkable advances in genetic science and technology have been made in the five decades since the landmark discovery of the double-helix structure of DNA in April 1953. Now, in the very month and year of the 50th anniversary of that important discovery by Watson and Crick, the International Human Genome Sequencing Consortium has completed decoding all the chapters of the instruction book of human life. This information is now freely available to the world without constraints via public databases on the World Wide Web. This genetic sequence provides us with the fundamental platform for understanding ourselves, from which revolutionary progress will be made in biomedical sciences and in the health and welfare of humankind. Thus, we take today an important step toward establishing a healthier future for all the peoples of the globe, for whom the human genome serves as a common inheritance. We congratulate all the people who participated in this project on their creativity and dedication. Their outstanding work will be noted in the history of science and technology, and as well in the history of humankind, as a landmark achievement. We encourage the world to celebrate the scientific achievement of completing the Human Genome Project, and we exhort the scientific and medical communities to rededicate themselves to the utilization of these new discoveries to reduce human suffering. -
The Bermuda Triangle: the Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project
Journal of the History of Biology (2018) 51:693–805 https://doi.org/10.1007/s10739-018-9538-7 The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project 1,2 3 4 Kathryn Maxson Jones • Rachel A. Ankeny • Robert Cook-Deegan Published online: 2 November 2018 Ó The Author(s) 2018 Abstract The Bermuda Principles for DNA sequence data sharing are an enduring legacy of the Human Genome Project (HGP). They were adopted by the HGP at a strategy meeting in Bermuda in February of 1996 and implemented in formal policies by early 1998, mandating daily release of HGP-funded DNA sequences into the public domain. The idea of daily sharing, we argue, emanated directly from strategies for large, goal-directed molecular biology projects first tested within the ‘‘community’’ of C. elegans researchers, and were introduced and defended for the HGP by the nematode biologists John Sulston and Robert Waterston. In the C. elegans com- munity, and subsequently in the HGP, daily sharing served the pragmatic goals of quality control and project coordination. Yet in the HGP human genome, we also argue, the Bermuda Principles addressed concerns about gene patents impeding scientific advancement, and were aspirational and flexible in implementation and justification. They endured as an archetype for how rapid data sharing could be realized and rationalized, and permitted adaptation to the needs of various scientific communities. Yet in addition to the support of Sulston and Waterston, their adoption also depended on the clout of administrators at the US National Institutes of Health (NIH) and the UK nonprofit charity the Wellcome Trust, which together funded 90% of the HGP human sequencing effort. -
Maynard Olson So, I'm Maynard Olson. I'm Professor Emeritus of Medicine
NHGRI: Maynard Olson 1 3/24/17 Maynard Olson So, I’m Maynard Olson. I’m Professor Emeritus of Medicine and Genome Sciences at the University of Washington. And the Emeritus part is for real. I actually did retire a few years ago and spend very little time at the University of Washington and am involved in a variety of other activities, but not any longer active in research. And I grew up in Bethesda, on Edgemoor Lane, yes. I -- my father was an intramural NIH researcher in the -- what was then called the Division of Infectious Diseases. And at that time responsibilities had not sorted out between the CDC and the NIH to the degree that they have now, and most of my father’s work was more similar to what goes on now with the CDC than what goes on at the -- in the NIAID. But, in any event, I kind of grew up in this culture and left -- I was born here and left my senior year in high school but -- and -- to the west coast where I’ve spent a lot of my time since then. But, I went through the public school in Bethesda. Bethesda Elementary, the no longer extent Leland Junior High school and BCC. I can remember -- I can remember the NIH campus when I was a young child. Still rented some of the land to a neighboring farmer to graze cows on because the initial land gift here was larger than the NIH could put to scientific use at that time, and that was when the NIH, particularly to the north, was surrounded by farm land. -
The Nobel Prize for Physiology Or Medicine 2002
PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central The Nobel Prize for Physiology or Medicine 2002 ArticleInfo ArticleID : 4602 ArticleDOI : 10.1186/gb-spotlight-20021008-01 ArticleCitationID : gb-spotlight-20021008-01 ArticleSequenceNumber : 268 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 4 RegistrationDate : 2002–10–8 ArticleHistory : OnlineDate : 2002–10–8 ArticleCopyright : BioMed Central Ltd2002 ArticleGrants : ArticleContext : 130593311 David Bruce Email: [email protected] In a move that many will regard as long overdue, the Nobel committee honoured Sydney Brenner with the Nobel Prize for Physiology or Medicine. John Sulston and Robert Horvitz will share the prize, which has been awarded in recognition of the triumvirate's seminal studies on the nematode worm Caenorhabditis elegans. Their discoveries concerning genetic regulation of organ development and programmed cell death have given insights into these processes in many other organisms. In the early 1960s, Sydney Brenner - then at the MRC-LMB in Cambridge and currently a Distinguished Professor at The Salk Institute, California, USA - realized that it would be impossible to use a mammalian system as a tool for studies on cell differentiation and organ development. He identified the nematode Caenorhabditis elegans as an ideal experimental organism because of its short generation time, small cell number (959 cells in the adult) and amenability to examination by both light and electron microscopy. In 1974 he further extended understanding of the worm by showing that ethyl methane sulfonate (EMS) could be used to induce genetic mutations and that these had specific effects on organ development. The worm's amenability to fixation and thin sectioning enabled Brenner to undertake a detailed examination of its nervous system, leading to the publication in 1986 of a complete map of the C.